Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 27, 2022 Filed May 31, 2022 18:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 44,629 | $319.38 | $14,253,520.76 |
DisclosureSEC source: 0001209191-22-032783 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,896,157 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.85 to $319.845, inclusive. Read SEC document |
| May 27, 2022 Filed May 31, 2022 18:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 26,801 | $318.56 | $8,537,592.56 |
DisclosureSEC source: 0001209191-22-032783 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,940,786 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.85 to $318.845, inclusive. Read SEC document |
| May 27, 2022 Filed May 31, 2022 18:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 36,194 | $317.16 | $11,479,144.26 |
DisclosureSEC source: 0001209191-22-032783 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,967,587 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.85 to $317.84, inclusive. Read SEC document |
| May 27, 2022 Filed May 31, 2022 18:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 12,324 | $316.44 | $3,899,818.88 |
DisclosureSEC source: 0001209191-22-032783 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,003,781 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.85 to $316.84, inclusive. Read SEC document |
| May 27, 2022 Filed May 31, 2022 18:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 13,605 | $315.28 | $4,289,370.80 |
DisclosureSEC source: 0001209191-22-032783 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,016,105 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.85 to $315.84, inclusive. Read SEC document |
| May 27, 2022 Filed May 31, 2022 18:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,100 | $314.44 | $1,289,204.00 |
DisclosureSEC source: 0001209191-22-032783 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,029,710 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.84 to $314.83, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4. Read SEC document |
| May 26, 2022 Filed May 27, 2022 14:58 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 48,492 | $313.31 | $15,193,125.50 |
DisclosureSEC source: 0001209191-22-032406 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,033,810 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.02 to $313.81, inclusive. Read SEC document |
| May 26, 2022 Filed May 27, 2022 14:58 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 19,659 | $312.75 | $6,148,332.59 |
DisclosureSEC source: 0001209191-22-032406 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,082,302 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.02 to $313.00, inclusive. Read SEC document |
| May 26, 2022 Filed May 27, 2022 14:58 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 32,093 | $311.59 | $9,999,922.06 |
DisclosureSEC source: 0001209191-22-032406 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,101,961 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.02 to $312.01, inclusive. Read SEC document |
| May 26, 2022 Filed May 27, 2022 14:58 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 21,321 | $310.50 | $6,620,234.46 |
DisclosureSEC source: 0001209191-22-032406 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,134,054 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.00 to $310.97, inclusive. Read SEC document |
| May 26, 2022 Filed May 27, 2022 14:58 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 32,150 | $309.56 | $9,952,450.45 |
DisclosureSEC source: 0001209191-22-032406 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,155,375 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.00 to $309.99, inclusive. Read SEC document |
| May 26, 2022 Filed May 27, 2022 14:58 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 24,675 | $308.52 | $7,612,755.68 |
DisclosureSEC source: 0001209191-22-032406 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,187,525 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.00 to $308.9875, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5) and (6) to this Form 4. Read SEC document |
| May 25, 2022 Filed May 26, 2022 15:40 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,082 | $310.14 | $645,701.07 |
DisclosureSEC source: 0001209191-22-032080 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,212,200 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.06 to $310.275, inclusive. Read SEC document |
| May 25, 2022 Filed May 26, 2022 15:40 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 17,146 | $309.65 | $5,309,173.17 |
DisclosureSEC source: 0001209191-22-032080 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,214,282 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.01 to $309.99, inclusive. Read SEC document |
| May 25, 2022 Filed May 26, 2022 15:40 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 22,382 | $308.30 | $6,900,392.98 |
DisclosureSEC source: 0001209191-22-032080 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,231,428 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.00 to $308.97, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| May 24, 2022 Filed May 25, 2022 15:37 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 44,965 | $306.28 | $13,771,835.24 |
DisclosureSEC source: 0001209191-22-031796 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,253,810 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.0197 to $306.88, inclusive. Read SEC document |
| May 24, 2022 Filed May 25, 2022 15:37 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 55,035 | $305.74 | $16,826,125.73 |
DisclosureSEC source: 0001209191-22-031796 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,298,775 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.00 to $305.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| May 23, 2022 Filed May 24, 2022 16:51 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,363 | $304.36 | $1,632,271.95 |
DisclosureSEC source: 0001209191-22-031552 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,353,810 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.00 to $304.81, inclusive. Read SEC document |
| May 23, 2022 Filed May 24, 2022 16:51 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 33,960 | $303.40 | $10,303,464.00 |
DisclosureSEC source: 0001209191-22-031552 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,359,173 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.00 to $303.95, inclusive. Read SEC document |
| May 23, 2022 Filed May 24, 2022 16:51 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 79,533 | $302.34 | $24,045,927.69 |
DisclosureSEC source: 0001209191-22-031552 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,393,133 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.00 to $302.9901, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| May 18, 2022 Filed May 19, 2022 14:08 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 700 | $302.00 | $211,400.00 |
DisclosureSEC source: 0001209191-22-030328 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,472,666 Read SEC document |
| May 17, 2022 Filed May 18, 2022 17:11 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 300 | $303.22 | $90,966.90 |
DisclosureSEC source: 0001209191-22-029969 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,473,366 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.11 to $303.30, inclusive. Read SEC document |
| May 17, 2022 Filed May 18, 2022 17:11 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 19,383 | $302.24 | $5,858,376.07 |
DisclosureSEC source: 0001209191-22-029969 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,473,666 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.00 to $302.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| May 16, 2022 Filed May 17, 2022 15:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 14,161 | $303.08 | $4,291,887.56 |
DisclosureSEC source: 0001209191-22-029498 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,493,049 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.00 to $303.22, inclusive. Read SEC document |
| May 16, 2022 Filed May 17, 2022 15:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 66,600 | $302.42 | $20,141,105.40 |
DisclosureSEC source: 0001209191-22-029498 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,507,210 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.00 to $302.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:34 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 33 | $299.38 | $9,879.54 |
DisclosureSEC source: 0000059478-22-000149 · wf-form4_165290583163311.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,236 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:40 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 47 | $299.38 | $14,070.86 |
DisclosureSEC source: 0000059478-22-000151 · wf-form4_165290636559500.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,773 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:42 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 33 | $299.38 | $9,879.54 |
DisclosureSEC source: 0000059478-22-000153 · wf-form4_165290650982068.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 864 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:45 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 18 | $299.38 | $5,388.84 |
DisclosureSEC source: 0000059478-22-000155 · wf-form4_165290668573559.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:48 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 32 | $299.38 | $9,580.16 |
DisclosureSEC source: 0000059478-22-000157 · wf-form4_165290682953920.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,234 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| May 16, 2022 Filed May 18, 2022 21:04 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 38 | $299.38 | $11,376.44 |
DisclosureSEC source: 0000059478-22-000159 · wf-form4_165290743133946.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,492 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 20:20 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 38 | $298.82 | $11,355.16 |
DisclosureSEC source: 0000059478-22-000119 · wf-form4_165039964093794.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,454 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 20:23 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 33 | $298.82 | $9,861.06 |
DisclosureSEC source: 0000059478-22-000121 · wf-form4_165039979278907.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,203 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 20:27 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 42 | $298.82 | $12,550.44 |
DisclosureSEC source: 0000059478-22-000125 · wf-form4_165040001395736.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,726 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 20:25 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 32 | $298.82 | $9,562.24 |
DisclosureSEC source: 0000059478-22-000123 · wf-form4_165039989320375.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,202 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 20:29 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 33 | $298.82 | $9,861.06 |
DisclosureSEC source: 0000059478-22-000127 · wf-form4_165040013132753.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 831 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 18:26 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,906 | $312.13 | $907,038.16 |
DisclosureSEC source: 0001209191-22-023969 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,573,810 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.005 to $312.31, inclusive. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 18:26 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 66,345 | $311.37 | $20,657,975.34 |
DisclosureSEC source: 0001209191-22-023969 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,576,716 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.005 to $311.99, inclusive. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 18:26 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 43,757 | $310.66 | $13,593,637.13 |
DisclosureSEC source: 0001209191-22-023969 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,643,061 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.005 to $311.00, inclusive. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 18:26 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 26,037 | $309.37 | $8,055,144.80 |
DisclosureSEC source: 0001209191-22-023969 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,686,818 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.00 to $309.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 19:20 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,387 | $311.36 | $3,234,044.39 |
DisclosureSEC source: 0001209191-22-023822 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,712,855 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.01 to $311.875, inclusive. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 19:20 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 19,230 | $310.49 | $5,970,703.47 |
DisclosureSEC source: 0001209191-22-023822 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,723,242 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.00 to $310.995, inclusive. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 19:20 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 41,338 | $309.12 | $12,778,237.21 |
DisclosureSEC source: 0001209191-22-023822 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,742,472 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.00 to $309.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,721 | $306.20 | $1,445,570.20 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 11 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,783,810 F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.8628 to $306.43, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,556 | $305.12 | $1,084,992.50 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 10 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,788,531 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.69 to $305.68, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,800 | $304.26 | $547,669.80 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,792,087 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.64 to $304.55, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,059 | $303.17 | $1,533,737.03 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,793,887 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.57 to $303.53, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,884 | $301.99 | $2,078,878.51 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,798,946 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.57 to $302.56, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,276 | $301.04 | $1,287,259.87 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,805,830 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.56 to $301.55, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,943 | $300.10 | $2,083,601.24 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,810,106 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.57 to $300.55, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.